Corvus Pharmaceuticals Inc (CRVS) is around the top of the Biotechnology industry according to InvestorsObserver. CRVS received an overall rating of 71, which means that it scores higher than 71 percent of all stocks. Corvus Pharmaceuticals Inc also achieved a score of 91 in the Biotechnology industry, putting it above 91 percent of Biotechnology stocks. Biotechnology is ranked 51 out of the 148 industries.
CRVS has an Overall Score of 71. Find out what this means to you and get the rest of the rankings on CRVS!
Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.
What's Happening With Corvus Pharmaceuticals Inc Stock Today?
Corvus Pharmaceuticals Inc (CRVS) stock is trading at $1.39 as of 9:53 AM on Tuesday, Nov 14, an increase of $0.06, or 4.51% from the previous closing price of $1.33. The stock has traded between $1.25 and $1.45 so far today. Volume today is 204,374 compared to average volume of 197,905.
Click Here to get the full Stock Report for Corvus Pharmaceuticals Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
